Annual EBITDA
-$5.35 M
-$1.92 M-56.12%
31 December 2023
Summary:
Conduit Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$5.35 million, with the most recent change of -$1.92 million (-56.12%) on 31 December 2023. CDTTW annual EBITDA is now -93.59% below its all-time high of -$2.76 million, reached on 31 December 2021.CDTTW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$5.96 M
-$611.00 K-11.42%
30 September 2024
Summary:
Conduit Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$5.96 million, with the most recent change of -$611.00 thousand (-11.42%) on 30 September 2024. Over the past year, it has dropped by -$5.32 million (-838.43%). CDTTW quarterly EBITDA is now -382.55% below its all-time high of $2.11 million, reached on 31 December 2023.CDTTW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$12.63 M
-$5.32 M-72.86%
30 September 2024
Summary:
Conduit Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$12.63 million, with the most recent change of -$5.32 million (-72.86%) on 30 September 2024. Over the past year, it has dropped by -$12.00 million (-1889.13%). CDTTW TTM EBITDA is now -956.92% below its all-time high of $1.47 million, reached on 31 December 2023.CDTTW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTTW EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.1% | -838.4% | -1889.1% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CDTTW EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -93.6% | at low | -382.6% | at low | -956.9% | at low |
| 5 y | 5 years | -93.6% | at low | -382.6% | at low | -956.9% | at low |
| alltime | all time | -93.6% | at low | -382.6% | at low | -956.9% | at low |
Conduit Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.96 M(+11.4%) | -$12.63 M(+72.9%) |
| June 2024 | - | -$5.35 M(+55.8%) | -$7.31 M(+273.0%) |
| Mar 2024 | - | -$3.43 M(-262.8%) | -$1.96 M(-232.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$5.35 M(+56.1%) | $2.11 M(-432.1%) | $1.47 M(-332.1%) |
| Sept 2023 | - | -$635.00 K | -$635.00 K |
| Dec 2022 | -$3.42 M(+24.0%) | - | - |
| Dec 2021 | -$2.76 M | - | - |
FAQ
- What is Conduit Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals annual EBITDA year-on-year change?
- What is Conduit Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Conduit Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals TTM EBITDA year-on-year change?
What is Conduit Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CDTTW is -$5.35 M
What is the all time high annual EBITDA for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$2.76 M
What is Conduit Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, CDTTW annual earnings before interest, taxes, depreciation & amortization has changed by -$1.92 M (-56.12%)
What is Conduit Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CDTTW is -$5.96 M
What is the all time high quarterly EBITDA for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.11 M
What is Conduit Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, CDTTW quarterly earnings before interest, taxes, depreciation & amortization has changed by -$5.32 M (-838.43%)
What is Conduit Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CDTTW is -$12.63 M
What is the all time high TTM EBITDA for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is $1.47 M
What is Conduit Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, CDTTW TTM earnings before interest, taxes, depreciation & amortization has changed by -$12.00 M (-1889.13%)